Use of gluten immunogenic peptide (GIP) assays to provide objective confirmation of gluten ingestion will be one way to improve management of the patient with non-responsive coeliac disease. Dr Jason Tye-Din, head of the Coeliac Research Lab at the Walter and Eliza Hall Institute, told AGW 2018 that neither symptoms nor serology were reliable enough ...
Better tools required for non-responsive coeliac disease: Dr Jason Tye-Din
By Mardi Chapman
20 Sep 2018